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Neurodegenerative disorders (NDs) are heterogeneous groups of ailments typically characterized by progressive damage of the
nervous system. Several drugs are used to treat NDs but they have only symptomatic benefits with various side effects.
Numerous researches have been performed to prove the advantages of phytochemicals for the treatment of NDs. Furthermore,
phytochemicals such as polyphenols might play a pivotal role in rescue from neurodegeneration due to their various effects as
anti-inflammatory, antioxidative, and antiamyloidogenic agents by controlling apoptotic factors, neurotrophic factors (NTFs),
free radical scavenging system, and mitochondrial stress. On the other hand, neurotrophins (NTs) including nerve growth factor
(NGF), brain-derived neurotrophic factor (BDNF), NT4/5, and NT3 might have a crucial neuroprotective role, and their
diminution triggers the development of the NDs. Polyphenols can interfere directly with intracellular signaling molecules to
alter brain activity. Several natural products also improve the biosynthesis of endogenous genes encoding antiapoptotic Bcl-2 as
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well as NTFs such as glial cell and brain-derived NTFs. Various epidemiological studies have demonstrated that the initiation of
these genes could play an essential role in the neuroprotective function of dietary compounds. Hence, targeting NTs might
represent a promising approach for the management of NDs. In this review, we focus on the natural product-mediated
neurotrophic signal-modulating cascades, which are involved in the neuroprotective effects.
1. Introduction
Neurodegenerative disorders (NDs) are global health bur-
dens that result from the progressive defect of neural cells,
leading to dysfunction in the nervous system [1, 2]. The
World Health Organization (WHO) predicts that, by 2050,
people living with dementia are projected to triple from 50
million to 152 million [3]. Various NDs including Alzhei-
mer’s disease (AD), Huntington’s disease, amyotrophic lat-
eral sclerosis, Parkinson’s disease (PD), and frontotemporal
dementia exert a deleterious burden not only on the affected
persons but also on their family members as well as the soci-
ety [4, 5]. Every year, USA spends billions of dollars on unin-
terrupted health care expenses and lost profits, and it is
assessed that $100 billion is spent only on AD each year
[6]. Apart from these financial matters, there is a huge emo-
tional and pathetic burden on AD individuals and their care-
takers [7].
Several neurodegenerative diseases share similar patho-
genetic mechanisms at various steps of the disease develop-
ment including mitochondrial dysfunction, increased
nitrosative/oxidative stress, protein aggregation/misfolding,
loss of synaptic function, and reduced neuronal survival
[8–11]. While immune cells and neurons are exposed to
lethal proteins, higher energy is required to protect them
from the deposited nitrogen and oxygen species responsible
for neuronal damage. These latter induce a mitochondrial
dysfunction with the release of cytochrome c along with
other mitochondrial proteins thus leading to cell death [8,
10]. This protein accumulation disturbs cell signaling as
well as neuronal functions which are considered as the
main causes of neuronal disorders [12, 13].
Neurotrophins (NTs) or neurotrophic factors (NTFs) are
a group of essential growth factors, which are required for the
regulation, persistence, and renewal of certain neuronal cells
in the brain [14, 15]. NTs have been recognized as neuronal
survival-promoting proteins in animals and include nerve
growth factor (NGF), brain-derived neurotrophic factor
(BDNF), NT-3, and NT-4/5 [16, 17]. By modulating synaptic
plasticity, BDNF serves as a key molecule in neurodegenera-
tive diseases [18, 19]. Furthermore, BDNF gene delivery is a
potential therapy for tau pathology in Alzheimer’s disease
[20]. Some phytochemicals stimulate neuronal cell differenti-
ation and upregulate NTs including BDNF and NGF [21–
25]. Phytochemicals may thus have the potential to inhibit
neurodegeneration by triggering NTs and by upregulating
the function of several constituents of the antioxidant system,
for example, catalase and superoxide dismutase (SOD) [26,
27]. Also, they may hinder the formation of several inflam-
matory mediators and reactive oxygen species (ROS) such
as nitric oxide (NO), nuclear factor kappa B (NF-κB), intrin-
sic nitric oxide synthase (iNOS), tumor necrosis factor-α
(TNF-α), prostaglandin (PG) E2, and interleukin (IL)-1β.
NGF induces the tropomyosin receptor kinase (Trk) A sig-
naling cascade [21–24] by preventing the protein expression
pathway [28] and through the breakdown of amyloid β (Aβ)
peptides in the brain [29]. Among natural products, polyphe-
nols, in particular, initiate NTs and have antiapoptotic as well
as antioxidative actions in neurons. In this review, we present
the natural products that can modulate the neurotrophic sig-
nals to treat NDs.
2. Cellular Interactions between Neurotrophic
Factors and Their
Receptors for Neuroprotection
NTFs control the development, progression, plasticity, and
function of neurons and defend neuronal cells against apo-
ptosis [30]. NTFs are divided into the neurotrophic cytokines
(neurokines), the neurotrophin family, the glial cell line-
derived neurotrophic factor (GDNF) family of ligands, and
new NTF members, such as the mesencephalic astrocyte-
derived neurotrophic factor (MANF), the cerebral dopamine
neurotrophic factor (CDNF), the basic fibroblast growth fac-
tor (bFGF), and the ciliary neurotrophic factor (CNTF) [31].
NTs such as NGF, BDNF, NT-3, and NT-4 bind with two
distinct receptors, namely, Trk receptors and p75 neurotro-
phin receptor (p75NTR). The initiation of Trk receptors
stimulates the survival of neurons, while p75NTR induces
cell apoptosis. NTs have a selective high affinity to different
Trk receptors. For instance, TrkA displays a high affinity
toward NGF, whereas TrkB and TrKC show a higher affinity
toward BDNF and NT-3 and NT 4/5, respectively [32]. Sev-
eral NTFs including BDNF, NT-3, NGF, NT 4/5, bFGF-2,
and erythropoietin (EPO) prevent neurons from injury. Con-
sequently, they are capable of restoring NDs by interacting
with the Trk receptor and enhancing the growth, survival,
and regulation of neurons [33]. Among NTs, NGF was the
first identified growth factor and has been shown to improve
the survival of neurons and outgrowth of neurite ganglia in
terrestrial birds by using the tissues of mouse sarcoma [33].
NTs expedite distinct intracellular signaling pathways, such
as the Ras/extracellular signal-regulated kinases (ERK),
phosphatidylinositol 3-kinase (PI3K)/AKT, and phospholi-
pase Cγ pathways, through their binding to the related
receptors [34].
Furthermore, NTs activate downstream signaling targets
to control cell survival and enhance synaptic as well as
neurite outgrowth for maintaining cell volume or to increase
rescue from neurodegeneration [35]. NTs accelerate the tran-
scription of the Trk receptor via Brn3a, Kruppel-like factor 7,
c-Jun, NeuroD, and cAMP response element-binding
(CREB) protein [36]. NTs deficiency that inhibits the expres-
sion of the Trk receptor and may result in defects of the
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cognitive neurons. Interestingly, spicatoside A, a steroidal
saponin derived from Liriope platyphylla Wang et Tang,
enhances the release of NTFs in primary astrocyte cells
and C6 glioma to increase long-term potentiation [23,
37–39]. NTs also exhibit a weak affinity towards p75NTR
due to structural resemblances with the receptors of the
Trk family [40]. Importantly, p75NTR induces the cell
death promoting the TNF receptor superfamily involving
several factors, for instance, Fas ligand, TNF receptor-I,
TNF receptor-II, OX40, CD40, and TNF [41]. Dimeric
NTs interact with p75NTR monomers by the formation
of a disulfide bond with a cysteine-rich intracellular
repeating domain as well as causing a structural alteration
of the receptor [42–44]. This alteration then triggers an
enzymatic induction of an adaptor protein by c-Jun N-
terminal kinase (JNK) and NF-κB that lead to proliferation
as well as survival through B cell lymphoma-2 (Bcl-2), or
apoptosis via caspases [42–44].
NT binding causes the initiation of the Trk receptor,
triggering oligomerization and transautophosphorylation
of the tyrosine moiety in the intracellular domain. This
event subsequently leads to the initiation of signaling
transduction inside the cell through stimulation of the
Ras/mitogen-activated protein kinase (MAPK) pathway
resulting in CREB-dependent NT secretion and expression
of Bcl-2, which finally enhances cell survival, development,
and proliferation [45]. Apart from analyses reporting on
the functions of NGF itself, analyses of NGF mimetics
along with NGF inducers are currently in development.
NGF can improve the cellular growth rate and differentia-
tion and the development of neurite, which can positively
enhance memory and learning in AD patients [46, 47].
Also, NT insufficiency plays a pivotal role in neuropathy
[48]; thus, research on phytochemicals that can potentiate
NT is essential to combat NDs [44]. In the brain, neuro-
trophic factors cannot pass through the blood-brain barrier
(BBB), and various approaches have been used to increase
their delivery [49, 50]. Furthermore, GDNF had adminis-
tered into the putamen either directly or indirectly by
the transplantation of GDNF-producing cells as well as
by using gene therapy employing recombinant lentiviruses
or adeno-associated viruses in some clinical studies with
PD patients [51, 52]. As a different delivery approach,
small molecules that can penetrate through the BBB have
been advocated to enhance the endogenous NTF expres-
sion for clinical trials. Levodopa and dopamine agonists,
glutamate antagonists, antipsychotics, and antidepressants
increase the level of GDNF and BDNF in the brain [19,
53–55]. Selegiline and rasagiline elevate the level of BDNF
and GDNF in the cerebrospinal fluid in cellular and ani-
mal models as well as PD patients [56–59]. Ras-PI3K-
Akt survival pathway activation could play a role in rasagi-
line’s neuroprotective effect in post-1-methyl-4-phenyl-1,
2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism
[56]. Study also found that selegiline possesses trophic-
like properties that are independent of MAO-B inhibition.
Selegiline enhances NGF formation and protects neurons
from excitotoxicity and ischemia in the central nervous
system [57].
3. Neurotrophic Activity of Natural
Products for Neuroprotection
Epigallocatechin gallate (EGCG), curcumin, epicatechin,
quercetin, resveratrol, and citrus flavonoids (i.e., hesperetin
and naringenin), all these compounds being polyphenols,
can pass through the BBB and possess the function like
NTF in the brain [60]. Various phytochemicals display neu-
rotrophic functions by attaching with NTF receptors leading
to initiation of the downstream signaling cascades as well as




(7,8-DHF), and deoxygedunin are polyphenols which form
complexes by binding to TrkB, initiating PI3K-Akt-ERK cas-
cade, enhancing BDNF, and facilitating survival of spinal
ganglion neurons, hippocampal neurons, and cultivated
motor neurons [61, 62]. Curcumin triggers TrkB-MAP
kinase along with PI3K pathways, elevates the BDNF level,
and prevents cerebral cortical neurons from glutamate
excitotoxicity in rats [63]. A naturally occurring compound,
6-methylsufinylhexyl isothiocyanate (6-HITC, an analogue
of sulforaphane), extracted from Wasabia japonica (Miq.),
intensely improved the neurite outgrowth and the expression
of light neurofilament-L and TrkA phosphorylation in the
presence of NGF because 6-HITC that inhibits the activity
of protein tyrosine phosphatase 1B, a specific phosphatase
that affects the phosphorylation status of TrkA [64]. Gambo-
gic amide, a natural compound used in Chinese medicine,
also triggers the TrkA and neuroprotective signaling path-
ways [65]. In contrast, epicatechin was proven to prevent
the expression of p75NTFR and inhibit retinal neurodegen-
eration in diabetic rats [66].
Furthermore, apigenin inhibits p38 MAPK, ERK1/2, and
JNK as well as controls NGF-mediated neurite outgrowth in
PC12 cells [67]. Apigenin has also an obvious permeability
coefficient in the BBB, and therefore, it considers as a prom-
ising phytochemical for treating NDs [68]. Berberine treat-
ment inhibits the generation of Aβ-induced monocyte
chemotactic protein-1 and IL-6 and downregulated the
expression of iNOS and Cox-2 in primary microglia as well
as BV2 cells. This antineuroinflammatory effect was accom-
plished probably through suppression of the NF-κB activation
[69]. Curcumin weakens Aβ mediated apoptosis by suppress-
ing the activation of NF-κB (Figure 1) stimulated by the
p75NTR cell death receptor [70]. According to the study by
Yang et al. [71], curcumin demonstrated a significant neuro-
protective action by upregulating the expressions of BDNF
TrkB and PI3K protein level via the activation of the
BDNF/TrkB dependent pathway in the 6-hydroxydopamine-
mediated PD rat model.
Phytochemicals stimulate other receptors for the regula-
tion of brain functions. In animal experiments, flavonoids
along with other phytochemicals have shown anxiolytic
activities via the binding with receptors called γ-aminobuty-
ric acid A (GABA-A) at the sites of nonbenzodiazepines and
benzodiazepines [72–75]. Furthermore, GABA receptors
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induce anthocyanin-mediated neuroprotection from ethanol
toxicity in prenatal rat hippocampal neurons [76] and by bai-
calin from global reoxygenation injury in gerbil neurons [77].
The α4 and α7 subunits of nicotinic acetylcholine receptors
are linked with the neuroprotection afforded by scutellarin
from Aβ1-42-induced cytotoxicity in rats [78] and by EGCG
in cultivated cortical neurons [79]. Curcumin prompts
serotonin-1A (5-HT1A) receptor and stimulates hippocam-
pal neurogenesis as well as the expression of BDNF in
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Figure 1: Role of phytochemicals involved in neuroprotection against neurodegeneration. Phytochemicals or neurotrophins bind to Trk
receptor that subsequently activates PL-Cγ, Ras/MAPK, and PI3K/AKT pathways. Then, these signaling cascades trigger CREB that
ultimately plays a pivotal role in protecting neurons to combat neurodegeneration. Furthermore, phytochemicals or neurotrophins also
attach with NGF-p75NTR receptor and activate bidirectional cell survival and apoptosis through NF-κB and JNK signaling pathways.
4 Oxidative Medicine and Cellular Longevity
death induced by corticosterone [81]. In depressed mouse
model analyses, ethanol extracts of Hemerocallis citrina var.
vespertina initiate ERK as well as G protein-linked receptors
and subsequent cascades and exhibit antidepressant action
[82] by binding to 5-HT2, 5-HT1A, and dopaminergic D2
receptors as well as noradrenergic α1-, α2-, and β-adrenore-
ceptors. The ethanol extract of Scutellaria baicalensis Georgi.
protects cell cultures of primary rat cortical neurons against
glutamate toxicity by binding with the glycine-binding site
of the N-methyl-D-aspartate receptor [83]. Estrogen and
insulin-like growth factor-1 (IGF-1) receptors facilitate
NTF stimulation and neuronal protection by various flavo-
noids (i.e., calycosin, luteolin, ginsenoside Rg1, genistein) in
the PD rat model [84, 85].
4. Signal Regulating Potential of Natural
Products Involved in the
Neurotrophic Function
Most of the phytochemicals directly trigger enzymes and cellu-
lar signal molecules involved in neuroprotection (Figure 1) [86,
87]. Genistein, resveratrol, EGCG, and curcumin protect neu-
ronal cell cytotoxicity towards Aβ and 6-hydroxydopamine
(6-OHDA) by the initiation of the cytoprotective protein
kinase C (PKC) [88–91]. Phytochemicals activate tyrosine
kinase, MAPK, PKC, PI3K/Akt, Ras-MEK1/2-ERK1/2 signal-
ling pathway, and phosphorylate CREB, which play essential
roles in enhancing the expression of target genes by binding
with the CREB-binding protein (CBP) [92]. PKC-ERK1/2
signaling inhibits the decline of Bcl-2, Bcl-xL, and Bcl-w
and raises the cytotoxic caspases (caspase-1, -7, -10), Bax,
and Bad. Caffeine triggers the PI3K/Akt signaling cascade
and inhibits cell death in in vitro cellular PD models through
upregulation of the antiapoptotic Bcl-2 function [93].
Besides, ferulic acid deactivates Bad by reducing the down-
regulation of MEK-ERK-90 kDa ribosomal S6 kinase signal-
ing in ischemia rats [94]. Flavonoids initiate Akt-ERK1/2
signaling and prevent proapoptosis of Bim and Bad and ini-
tiation of caspases (i.e., caspase-3, caspase-9) to defend neu-
ral cells against death [95].
Carotenoids (i.e., lutein, astaxanthin, and lycopene)
stimulate nuclear factor erythroid-derived 2-related factor
2 (Nrf2) (Figure 2) by binding with the antioxidant
response element (ARE) and activate phase II enzymes
including glutathione S-transferases (GSTs), glutathione
reductase (GR), NAD(P)H quinone oxidoreductase, gluta-
thione peroxidase (GPx), and SOD [96]. Akt induces
phosphorylation of forkhead box O3 and activates NF-κB
that positively upregulates the expression of the Bcl-2 fam-
ily and caspase (-3, -6, -9) inhibitors and inhibits the p53
gene [97].
Resveratrol and the citrus flavanones hesperetin and
naringenin competitively block adenosine triphosphate
(ATP) binding of various protein kinases via linking to the
ATP-binding sites of the Ca2+ membrane ATPase, mito-
chondrial ATPase, PKC, and PKA [98]. Baicalein [99], car-
nosol, carnosic acid [100], and hydroxytyrosol (i.e., a
polyphenol from olive oil) [101] induce upregulation of
endogenous antioxidant systems by dissociating the negative
regulator, Kelch-like ECH association protein 1(Keap-1),
from Nrf2 to stimulate the Nrf2-ARE signaling cascade.
Moreover, initiation of polyphenol-mediated Nrf2-ARE sig-
naling exerts neuroprotective effect by inducing heme
oxygenase-1 (HO-1) expression in cultured neurons and
blocking oxidative stress [102]. HO-1 has been shown to
have anti-apoptotic effect. On the other hand phytochemi-
cals can also block the expression of various well-known
proapoptotic genes encoding Bax/Bad, cyclin-dependent
kinase inhibitor p21, caspase-1, and TNF-linked apoptosis-
inducing ligand [103].
5. Induction of the Neurotrophic Factor
Expression and Their Receptors by
Natural Products
In healthy individuals, coffee fruit extracts elevate plasma
BDNF concentrations [104]. In females with premenstrual
disorder, curcumin triggers the upregulation of serum
BDNF concentrations and improves ailment [105]. The
elevated expression of various NTFs and BDNF by phyto-
chemicals (Figure 3) in cellular as well as animal experi-
ments are appraised in Table 1. GDNF is induced by
smilagenin [106] and catalpol [107] in an animal experi-
ment of PD, in a rat model of EGCG-induced spinal cord
damage [108], and a mouse model of hesperidin-induced
depression [109].
Zhang et al. [135] found that chronic curcumin treat-
ments activate ERK or N-methyl-D-aspartate-CREB signal-
ing, accelerate the expression of BDNF, and enhance
pathological, biochemical, and behavioral changes in an
AD rat model induced by ventricular inoculation of Aβ1-42.
An established antidepressant used in China called Xiao
Chai Hu Tang (i.e., Minor Bupleurum Decoction) enhances
the expression of NGF, BDNF, TrkA, and TrkB in a rat hip-
pocampus of chronic mild stress [136]. In mouse, adminis-
tration of olive polyphenols accelerates the expression of
TrkB and TrkA, GDNF, and NGF in the olfactory bulbs
and hippocampus, but not in the frontal cortex and striatum
[137]. A Chinese herb, Rehmannia glutinous Libosch. used
for the dementia, elevates GDNF mRNA in primary cortical
astrocytes and C6 cells [138]. In the hippocampus, the initi-
ation of TrkB, TrkA, and BDNF expressions is related to the
antidepressant effects of phytochemicals via the progression
of adult neurogenesis [139]. Flavonoids activate BDNF both
in vitro and in vivo; however, GDNF is mainly activated by
catalpol, resveratrol, curcumin, and various nonflavonoids.
Flavonoids might enhance cognition, memory, as well as
depression, while curcumin and resveratrol improve neuro-
nal stress and inhibit apoptosis in AD and PD animal
models. Besides, in cell line experiments, ginkgolides, EGCG,
and curcumin derivatives accelerate the expression of BDNF
in U118MG glioma cells more significantly than in SH-SY5Y
neuroblastoma cells, advocating that glioblastoma cells may
play crucial roles in the initiation of BDNF gene using phy-
tochemicals [140].
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6. Activation of Other Neurotrophic
Pathways by Natural Products
Polyphenols that have numerous valuable functions in the
nervous system offer a significant resource for the advance-
ment of novel therapeutics for controlling NDs [141, 142].
Apart from the aforementioned signaling cascades associated
with polyphenol-based neurotrophic effects, several other
pathways might also be involved. Daidzein activity has
resulted in substantial axonal development through the over-
expression of the growth-associated protein (GAP)-43 in
hippocampal neuronal cell cultures. Remarkably, daidzein-
induced phosphorylation of GAP-43 and PKC has been





















Figure 2: Phytochemicals activate the Keap-Nrf2-antioxidant response element cascade to increase the expression of antioxidant enzymes
that fight against neurodegeneration.
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(ER) as well as PKC antagonist. These analyses advocate that
ER-induced PKC phosphorylation of GAP-43 may perform a
pivotal role in daidzein-prompted axonal development [143].
Similarly, hesperetin can show diverse neurotrophic actions
through TrkA- and ER-prompted parallel pathways [144].
The Na+/K+/2Cl− cotransporter (NKCC) belongs to a
member of the cation-chloride cotransporter family, which
is involved in the passage of chloride ion(s) together with
cation(s) through the plasma membrane [145]. Another

































































































































Figure 3: Chemical structures of the several phytochemicals that modulate the neurotrophic signals to attenuate neurodegeneration.
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PC12D cells overexpressed the NKCC1 protein [146].
Copious studies revealed that NKCC1 knockdown intensely
prevents NGF mediated-neurite development in PC12 cells.
Remarkably, quercetin also stimulated NGF-prompted neur-
ite development by rising Cl− ion levels, though NKCC1
knockdown suppressed this stimulation. In PC12 cells, the
intracellular chloride ion level influences microtubule poly-
merization through alteration of the inherent GTPase activ-
ity of tubulin [147].
A subclass of adenosine receptors A2A was demonstrated
to increase the BDNF expression and the synaptic function of
BDNF [148, 149]. Adenosine receptors also activate the TrkB
receptor as well as the Akt pathway that prompts neuronal
cell persistence and controls neurite development in various
cell types [150–152]. Recently, Jeon et al. [153] revealed that
oroxylin A might trigger BDNF outgrowth in cortical neu-
rons through the stimulation of the A2A receptor that medi-
ates neurite development, synapse formation, and cellular
survival. In a subsequent study, the adenosine A2A receptor
inhibitor was shown to inhibit methyl 3,4-dihydroxybenzo-
ate-mediated neurite development as well as neuronal sur-
vival in primary cultures of cortical neurons [154].
7. Inhibition of Neurotoxin-Induced Damage by
Natural Products and Associated
Neurotrophic Signaling
Experimental analyses have shown that Aβ is an essential
factor in AD pathogenesis [155, 156]. Numerous data pro-
pose that several polyphenols prevent neuronal cells from
Aβ mediated neuronal damage or cell death. For example,
icaritin has been revealed to defend primary rat cortical neu-
ronal cells from apoptosis mediated by Aβ25-35 insults [157].
Also, Ushikubo et al. [158] showed that 3,3′,4′,5,5′-penta-
hydroxyflavone prevents the deposition of Aβ fibrils and that
reducing fibril deposition and declines Aβ-mediated cell
death in rat hippocampal neuronal cells. In an alternative
analysis, p-coumaric acid, gallic acid, and ursolic acid iso-
lated from Japanese Cornus officinalis Sieb. et Zucc. were
proven to diminish proapoptotic functions including
changes of nuclear morphology, deoxyribonucleic acid divi-
sion, and Aβ-mediated cell blebbing in PC12 cells [159].
The primary flavonoids of cocoa, catechin, and epicatechin
defend PC12 cells against Aβ-mediated neurotoxicity [160].
The flavonoid liquiritin and a bioactive phenolic com-
pound (carnosic acid), extracted from Rosemary, display pro-
tection against Aβ in primary cultures of hippocampal
neurons and SH-SY5Y human neuroblastoma cells, respec-
tively [161, 162]. 6-Hydroxydopamine (6-OHDA) is a neuro-
toxic synthetic organic compound that triggers pathology-
like PD both in cellular and animal models. The trihydroxy-
flavone baicalein [163], caffeic acid derivatives, and ferulic
acid [164] defend SH-SY5Y neuronal cells against 6-
OHDA-induced neurotoxicity. Upon experimental analyses,
ROS and hydrogen peroxide have been shown to stimulate
neuronal cell injury [165]. In this case, numerous polyphe-
nols including 7,8-DHF in RGC-5 and retinal ganglion cells
(RGCs) [166], caffeic acid esters in PC12 cells [167], and
quercetin in cultivated neuronal ancestor cells [168] are pro-
viding protection against ROS. Moreover, other researchers
have proposed that the neuroprotective functions of 7,8-
DHF are induced by its capacity to enhance the levels of cel-
lular glutathione [169] by scavenging ROS.
Additional neurotoxins have also been employed to set
up investigational trials to evaluate the neuroprotective capa-
bility of polyphenolic compounds. Caffeic acid phenethyl
ester (CAPE) prevents PC12 cells from dopaminergic neuro-
toxin 1-methyl-4-phenylpyridinium [170]. In the mouse
brain, administration of 7,8-DHF decreases neuronal cell
death stimulated by kainic acid [61]. Icariin, another diglyco-
sylated polyphenolic compound derived from kaempferol,
can protect a primary culture of rat hippocampal neuronal
cells from corticosterone-mediated death [171]. Similarly,
baicalein has been demonstrated to block necrotic cell death
injury in nasopharyngeal carcinomas (NPCs) and to reduce
the loss of radiation-induced hippocampal neurogenesis
[172]. Polyphenols also revealed beneficial effects in animal
experiments of NDs triggered by diverse neurotoxins. Oral
intake of luteolin alleviates memory and learning dysfunc-
tions, in an Aβ-stimulated mice model of amnesia [173].
Curcumin, derived from Curcuma longa L., has also been
demonstrated to be efficient in inhibiting tau hyperpho-
sphorylation, neuroinflammation, and behavioral damages,
induced by Aβ in vivo [115].
8. Conclusion
The cellular mechanisms underlying the neuroprotective
activity of phytochemicals must be elucidated to uncover a
novel approach for developing drugs that able to interfere
in the deterioration of brain activity in aging and age-
related NDs. Mounting evidence recommends that enough
attention should be paid towards clinical trials including
these compounds. Therefore, it is essential to confirm the
neuroprotective effects of these phytochemicals in various
preclinical models and humans.
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